Immune and molecular determinants of response to neoadjuvant chemotherapy in inflammatory breast cancer.

被引：1
|
作者：
Reddy, Sangeetha Meda
Wargo, Jennifer Ann
Reuben, Alexandre
Tetzlaff, Michael T.
Roszik, Asori
Reuben, James M.
Woodward, Wendy A.
Ueno, Naoto T.
Krishnamurthy, Savitri
Mittendorf, Elizabeth Ann
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11501
引用
收藏
页数：6
相关论文
共 50 条
  • [41] GENE MODULES AND PATHOLOGICAL COMPLETE RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER. A POOLED ANALYSIS
    Ignatiadis, M.
    Singhal, S. K.
    Desmedt, C.
    Haibe-Kains, B.
    Criscitiello, C.
    Andre, F.
    Loi, S.
    Piccart, M.
    Michiels, S.
    Sotiriou, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 17 - 17
  • [42] Pathological Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: The Relationship Between Inflammatory Biomarkers and Molecular Subtypes
    Tekyol, Kubra Kaytaz
    Gurleyik, Gunay
    Aktas, Aysegul
    Aker, Fugen
    Tanrikulu, Eda
    Tekyol, Davut
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [43] Response to neoadjuvant chemotherapy in histologic variants of bladder cancer.
    Viala, Caroline
    Viala, Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [44] Significance of systemic and local immune responses to the pathological therapeutic effect of neoadjuvant chemotherapy in breast cancer.
    Kim, Ryungsa
    Kawai, Ami
    Wakisaka, Megumi
    Funaoka, Yuri
    Sawada, Sayaka
    Shimoyama, Mika
    Yasuda, Naomi
    Hidaka, Masayuki
    Morita, Yukitaka
    Ohtani, Shoichiro
    Arihiro, Koji
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] Src as a novel molecular biomarker for response to neoadjuvant chemotherapy with sequential doxorubicin and docetaxel in high-risk breast cancer.
    Minton, SE
    Munster, PN
    Cox, C
    Lacevic, M
    Lee, JH
    Beam, CA
    Muro-Cacho, CA
    Diaz, N
    Jove, R
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S53 - S54
  • [46] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Maria, G.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S95 - S95
  • [47] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    BREAST, 2017, 32 : S79 - S79
  • [48] PREDICTION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN BREAST CANCER
    Myllys, Maiju
    EXCLI JOURNAL, 2021, 20 : 625 - 627
  • [49] MANAGEMENT OF INFLAMMATORY BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPY
    Abrous-Anane, Soumya
    Savignoni, Alexia
    Daveau, Caroline
    Pierga, Jean-Yves
    Gautier, Chantal
    Reyal, Fabien
    Dendale, Remi
    Campana, Francois
    Kirova, Youlia M.
    Fourquet, Alain
    Bollet, Marc A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1055 - 1063
  • [50] The breast cancer immune microenvironment is modified by neoadjuvant chemotherapy
    Claudia Urueña
    Paola Lasso
    David Bernal-Estevez
    Diego Rubio
    Ana Janeth Salazar
    Mercedes Olaya
    Alfonso Barreto
    Mauricio Tawil
    Lilian Torregrosa
    Susana Fiorentino
    Scientific Reports, 12
12345